{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T21:06:44Z","timestamp":1761253604068},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study aims to investigate the association between CD4<jats:sup>+<\/jats:sup>T cell count and combined antiretroviral therapy (cART) with the prevalence of anal human papillomavirus (HPV) infection among HIV-positive male cohort in China.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A survey was conducted in men from a HIV cohort in Taizhou, China between 2016 and 2019. A face-to-face questionnaire interview was administered, and an anal-canal swab was collected for HPV genotyping.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 766 HIV-positive men were recruited. The HPV prevalence was lower among those with increased CD4<jats:sup>+<\/jats:sup>T cell count than those with decreased or unchanged (46.5 vs. 56.6%, p\u2009=\u20090.033) from baseline. In multivariable models, having the current CD4<jats:sup>+<\/jats:sup>T cell count of 350\u2013499 cells\/\u00b5L (aOR 0.28, 95% CI 0.13\u20130.64), and of\u2009\u2265\u2009500 cells\/\u00b5L (aOR 0.26, 95% CI 0.11\u20130.60) were associated with lower prevalence of any type HPV infection compared with those with\u2009&lt;\u2009200 cells\/\u00b5L. Having taken NVP\u2009+\u20093TC\u2009+\u2009AZT was inversely associated with any high-risk (HR)-HPV (aOR 0.47, 95% CI 0.25\u20130.90) and any low-risk (LR)-HPV\u00a0infection (aOR 0.40, 95% CI 0.18\u20130.88), compared with those taking EFV\u2009+\u20093TC\u2009+\u2009TDF.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Increased CD4<jats:sup>+<\/jats:sup>T cell count at follow-up was significantly associated with lower prevalence of anal HPV infection. Inverse associations between NVP\u2009+\u20093TC\u2009+\u2009AZT and HR-HPV or LR-HPV infecton were observed.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12879-022-07251-3","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T10:04:12Z","timestamp":1647252252000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Increased CD4+ T cell count is associated with lower anal human papillomavirus prevalence among HIV-positive male cohort in Taizhou, China: a cross-sectional study"],"prefix":"10.1186","volume":"22","author":[{"given":"Jing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiwen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhebin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiyang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,14]]},"reference":[{"key":"7251_CR1","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","volume":"87","author":"FX Bosch","year":"1995","unstructured":"Bosch FX, Manos MM, Mu\u00f1oz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995;87:796\u2013802.","journal-title":"J Natl Cancer Inst"},{"key":"7251_CR2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","volume":"7","author":"S de Sanjos\u00e9","year":"2007","unstructured":"de Sanjos\u00e9 S, Diaz M, Castellsagu\u00e9 X, Clifford G, Bruni L, Mu\u00f1oz N, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7:453\u20139.","journal-title":"Lancet Infect Dis"},{"key":"7251_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers8080075","author":"T Spence","year":"2016","unstructured":"Spence T, Bruce J, Yip KW, Liu F-F. HPV associated head and neck cancer. Cancers. 2016. https:\/\/doi.org\/10.3390\/cancers8080075.","journal-title":"Cancers"},{"key":"7251_CR4","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","volume":"141","author":"C de Martel","year":"2017","unstructured":"de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141:664\u201370.","journal-title":"Int J Cancer"},{"key":"7251_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/QAD.0000000000000909","volume":"30","author":"SH Mooij","year":"2016","unstructured":"Mooij SH, van Santen DK, Geskus RB, van der Sande MAB, Coutinho RA, Stolte IG, et al. The effect of HIV infection on anal and penile human papillomavirus incidence and clearance: a cohort study among MSM. AIDS Lond Engl. 2016;30:121\u201332.","journal-title":"AIDS Lond Engl"},{"key":"7251_CR6","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1097\/00002030-199810000-00010","volume":"12","author":"CW Critchlow","year":"1998","unstructured":"Critchlow CW, Hawes SE, Kuypers JM, Goldbaum GM, Holmes KK, Surawicz CM, et al. Effect of HIV infection on the natural history of anal human papillomavirus infection. AIDS. 1998;12:1177\u201384.","journal-title":"AIDS"},{"key":"7251_CR7","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/cid\/cir1012","volume":"54","author":"MJ Silverberg","year":"2012","unstructured":"Silverberg MJ, Lau B, Justice AC, Engels E, Gill MJ, Goedert JJ, et al. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis Off Publ Infect Dis Soc Am. 2012;54:1026\u201334.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"7251_CR8","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1097\/QAD.0b013e3283023f78","volume":"22","author":"C Piketty","year":"2008","unstructured":"Piketty C, Selinger-Leneman H, Grabar S, Duvivier C, Bonmarchand M, Abramowitz L, et al. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS Lond Engl. 2008;22:1203\u201311.","journal-title":"AIDS Lond Engl"},{"key":"7251_CR9","doi-asserted-by":"publisher","first-page":"e0124499","DOI":"10.1371\/journal.pone.0124499","volume":"10","author":"T Supindham","year":"2015","unstructured":"Supindham T, Chariyalertsak S, Utaipat U, Miura T, Ruanpeng D, Chotirosniramit N, et al. High prevalence and genotype diversity of anal HPV infection among MSM in Northern Thailand. PLoS ONE. 2015;10:e0124499.","journal-title":"PLoS ONE"},{"issue":"71","key":"7251_CR10","first-page":"437","volume":"2016","author":"AL Hernandez","year":"1999","unstructured":"Hernandez AL, Karthik R, Sivasubramanian M, Raghavendran A, Gnanamony M, Lensing S, et al. Prevalence of anal HPV infection among HIV-positive men who have sex with men in India. J Acquir Immune Defic Syndr. 1999;2016(71):437\u201343.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"7251_CR11","doi-asserted-by":"publisher","first-page":"e0139524","DOI":"10.1371\/journal.pone.0139524","volume":"10","author":"MM Blas","year":"2015","unstructured":"Blas MM, Brown B, Menacho L, Alva IE, Silva-Santisteban A, Carcamo C. HPV prevalence in multiple anatomical sites among men who have sex with men in peru. PLoS ONE. 2015;10:e0139524.","journal-title":"PLoS ONE"},{"key":"7251_CR12","doi-asserted-by":"crossref","unstructured":"Ablanedo-Terrazas Y, Romero-Mora K, G\u00f3mez-Palacio M, Alvarado-de la Barrera C, Ruiz-Cruz M, Hern\u00e1ndez-Juan R, et al. Prevalence and risk factors for oral human papillomavirus infection in Mexican HIV-infected men. Salud Publica Mex. 2018;60:653\u20137.","DOI":"10.21149\/9834"},{"key":"7251_CR13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1177\/0956462418797864","volume":"30","author":"RD Cranston","year":"2019","unstructured":"Cranston RD, Carballo-Di\u00e9guez A, Gundacker H, Richardson BA, Giguere R, Dolezal C, et al. Prevalence and determinants of anal human papillomavirus infection in men who have sex with men and transgender women. Int J STD AIDS. 2019;30:154\u201362.","journal-title":"Int J STD AIDS"},{"key":"7251_CR14","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1002\/jmv.23413","volume":"84","author":"S-H Cheng","year":"2012","unstructured":"Cheng S-H, Chu F-Y, Lin Y-S, Hsueh Y-M. Influence of age and CD4+ T cell counts on the prevalence of genital human papillomavirus infection among HIV-seropositive men who have sex with men in Taiwan. J Med Virol. 2012;84:1876\u201383.","journal-title":"J Med Virol"},{"key":"7251_CR15","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1093\/infdis\/jit374","volume":"208","author":"LM Schwartz","year":"2013","unstructured":"Schwartz LM, Castle PE, Follansbee S, Borgonovo S, Fetterman B, Tokugawa D, et al. Risk factors for anal HPV infection and anal precancer in HIV-infected men who have sex with men. J Infect Dis. 2013;208:1768\u201375.","journal-title":"J Infect Dis"},{"key":"7251_CR16","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/aje\/kwt153","volume":"178","author":"B Bertisch","year":"2013","unstructured":"Bertisch B, Franceschi S, Lise M, Vernazza P, Keiser O, Sch\u00f6ni-Affolter F, et al. Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study. Am J Epidemiol. 2013;178:877\u201384.","journal-title":"Am J Epidemiol"},{"key":"7251_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ypmed.2014.09.011","volume":"69","author":"L Torres-Ibarra","year":"2014","unstructured":"Torres-Ibarra L, Conde-Glez CJ, Salmer\u00f3n J, Palefsky J, Hern\u00e1ndez-Nevares P, S\u00e1nchez-Alem\u00e1n MA, et al. Risk factors for anal HPV-16\/18 infection in Mexican HIV-infected men who have sex with men. Prev Med. 2014;69:157\u201364.","journal-title":"Prev Med"},{"key":"7251_CR18","doi-asserted-by":"publisher","first-page":"e19273","DOI":"10.1097\/MD.0000000000019273","volume":"99","author":"R Chambuso","year":"2020","unstructured":"Chambuso R, Ramesar R, Kaambo E, Murahwa AT, Abdallah MOE, De Sousa M, et al. Age, absolute CD4 count, and CD4 percentage in relation to HPV infection and the stage of cervical disease in HIV-1-positive women. Medicine (Baltimore). 2020;99:e19273.","journal-title":"Medicine (Baltimore)"},{"key":"7251_CR19","doi-asserted-by":"publisher","first-page":"e262","DOI":"10.1016\/S2352-3018(19)30434-5","volume":"7","author":"H Kelly","year":"2020","unstructured":"Kelly H, Chikandiwa A, Alemany Vilches L, Palefsky JM, de Sanjose S, Mayaud P. Association of antiretroviral therapy with anal high-risk human papillomavirus, anal intraepithelial neoplasia, and anal cancer in people living with HIV: a systematic review and meta-analysis. Lancet HIV. 2020;7:e262\u201378.","journal-title":"Lancet HIV"},{"key":"7251_CR20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41598-021-03913-5","volume":"12","author":"MG Don\u00e0","year":"2022","unstructured":"Don\u00e0 MG, Giuliani M, Rollo F, Vescio MF, Benevolo M, Giglio A, et al. Incidence and clearance of anal high-risk Human Papillomavirus infection and their risk factors in men who have sex with men living with HIV. Sci Rep. 2022;12:184.","journal-title":"Sci Rep"},{"key":"7251_CR21","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1086\/381681","volume":"38","author":"A Del Mistro","year":"2004","unstructured":"Del Mistro A, Bertorelle R, Franzetti M, Cattelan A, Torrisi A, Giordani MT, et al. Antiretroviral therapy and the clinical evolution of human papillomavirus-associated genital lesions in HIV-positive women. Clin Infect Dis Off Publ Infect Dis Soc Am. 2004;38:737\u201342.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"7251_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/1471-2334-10-295","volume":"10","author":"S Shrestha","year":"2010","unstructured":"Shrestha S, Sudenga SL, Smith JS, Bachmann LH, Wilson CM, Kempf MC. The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents. BMC Infect Dis. 2010;10:295.","journal-title":"BMC Infect Dis"},{"key":"7251_CR23","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1586\/14787210.2014.950229","volume":"12","author":"L Hampson","year":"2014","unstructured":"Hampson L, Oliver AW, Hampson IN. Using HIV drugs to target human papilloma virus. Expert Rev Anti Infect Ther. 2014;12:1021\u20133.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"7251_CR24","unstructured":"CDCTobaccoFree. Burden of Tobacco Use in the U.S. Centers for Disease Control and Prevention. 2021. https:\/\/www.cdc.gov\/tobacco\/campaign\/tips\/resources\/data\/cigarette-smoking-in-united-states.html. Accessed 28 Feb 2022."},{"key":"7251_CR25","volume-title":"Manual of National free antiretroviral treatment(ART)program for HIV\/AIDS in China","author":"National Center for AIDS\/STD Control and Prevention, ChinaCDC","year":"2016","unstructured":"National Center for AIDS\/STD Control and Prevention, ChinaCDC. Manual of National free antiretroviral treatment(ART)program for HIV\/AIDS in China. 4th ed. Beijing: People\u2019s Health Publishing House; 2016.","edition":"4"},{"key":"7251_CR26","unstructured":"List of Classifications \u2013 IARC Monographs on the Identification of Carcinogenic Hazards to Humans. https:\/\/monographs.iarc.who.int\/list-of-classifications. Accessed 28 Feb 2022."},{"key":"7251_CR27","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz N, Bosch FX, de Sanjos\u00e9 S, Herrero R, Castellsagu\u00e9 X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518\u201327.","journal-title":"N Engl J Med"},{"key":"7251_CR28","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1017\/S0950268818003205","volume":"147","author":"X Liu","year":"2019","unstructured":"Liu X, Lin H, Chen X, Shen W, Ye X, Lin Y, et al. Prevalence and genotypes of anal human papillomavirus infection among HIV-positive vs. HIV-negative men in Taizhou China. Epidemiol Infect. 2019;147:e117.","journal-title":"Epidemiol Infect"},{"key":"7251_CR29","doi-asserted-by":"publisher","first-page":"4890","DOI":"10.1038\/s41598-017-05138-x","volume":"7","author":"Z-Y Jin","year":"2017","unstructured":"Jin Z-Y, Liu X, Ding Y-Y, Zhang Z-F, He N. Cancer risk factors among people living with HIV\/AIDS in China: a systematic review and meta-analysis. Sci Rep. 2017;7:4890.","journal-title":"Sci Rep"},{"key":"7251_CR30","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1136\/sextrans-2017-053412","volume":"94","author":"X Ma","year":"2018","unstructured":"Ma X, Wang Q, Ong JJ, Fairley CK, Su S, Peng P, et al. Prevalence of human papillomavirus by geographical regions, sexual orientation and HIV status in China: a systematic review and meta-analysis. Sex Transm Infect. 2018;94:434\u201342.","journal-title":"Sex Transm Infect"},{"key":"7251_CR31","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/infdis\/jit090","volume":"207","author":"D Konopnicki","year":"2013","unstructured":"Konopnicki D, Manigart Y, Gilles C, Barlow P, de Marchin J, Feoli F, et al. Sustained viral suppression and higher CD4(+) T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in hiv-positive women. J Infect Dis. 2013;207:1723\u20139.","journal-title":"J Infect Dis"},{"key":"7251_CR32","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1258\/ijsa.2008.008359","volume":"20","author":"E Jong","year":"2009","unstructured":"Jong E, van Gorp ECM, Mulder JW, Tol A, Smits PHM. Effect of HIV viral load, CD4 cell count and antiretroviral therapy on human papillomavirus prevalence in urine samples of HIV-infected men. Int J Std Aids. 2009;20:262\u20134.","journal-title":"Int J Std Aids"},{"key":"7251_CR33","doi-asserted-by":"crossref","unstructured":"van der Snoek EM, van der Ende ME, den Hollander JC, Schutten M, Neumann H a. M, van Doornum GJJ. Use of highly active antiretroviral therapy is associated with lower prevalence of anal intraepithelial neoplastic lesions and lower prevalence of human papillomavirus in HIV-infected men who have sex with men. Sex Transm Dis. 2012;39:495\u2013500.","DOI":"10.1097\/OLQ.0b013e31825aa764"},{"key":"7251_CR34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/AOG.0b013e31819225cb","volume":"113","author":"P Paramsothy","year":"2009","unstructured":"Paramsothy P, Jamieson DJ, Heilig CM, Schuman PC, Klein RS, Shah KV, et al. The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology. Obstet Gynecol. 2009;113:26\u201331.","journal-title":"Obstet Gynecol"},{"key":"7251_CR35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/sextrans-2018-053636","volume":"95","author":"Q Wang","year":"2019","unstructured":"Wang Q, Ma X, Zhang X, Ong JJ, Jing J, Zhang L, et al. Human papillomavirus infection and associated factors for cervical intraepithelial neoplasia in women living with HIV in China: a cross-sectional study. Sex Transm Infect. 2019;95:140\u20134.","journal-title":"Sex Transm Infect"},{"key":"7251_CR36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1177\/135965350601100607","volume":"11","author":"L Hampson","year":"2006","unstructured":"Hampson L, Kitchener HC, Hampson IN. Specific HIV protease inhibitors inhibit the ability of HPV16 E6 to degrade p53 and selectively kill E6-dependent cervical carcinoma cells in vitro. Antivir Ther. 2006;11:813\u201325.","journal-title":"Antivir Ther"},{"key":"7251_CR37","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3851\/IMP1786","volume":"16","author":"G Batman","year":"2011","unstructured":"Batman G, Oliver AW, Zehbe I, Richard C, Hampson L, Hampson IN. Lopinavir up-regulates expression of the antiviral protein ribonuclease L in human papillomavirus-positive cervical carcinoma cells. Antivir Ther. 2011;16:515\u201325.","journal-title":"Antivir Ther"},{"key":"7251_CR38","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1097\/QAD.0b013e328351f7a5","volume":"26","author":"G Barillari","year":"2012","unstructured":"Barillari G, Iovane A, Bacigalupo I, Palladino C, Bellino S, Leone P, et al. Ritonavir or saquinavir impairs the invasion of cervical intraepithelial neoplasia cells via a reduction of MMP expression and activity. AIDS Lond Engl. 2012;26:909\u201319.","journal-title":"AIDS Lond Engl"},{"key":"7251_CR39","doi-asserted-by":"publisher","first-page":"e0147917","DOI":"10.1371\/journal.pone.0147917","volume":"11","author":"L Hampson","year":"2016","unstructured":"Hampson L, Maranga IO, Masinde MS, Oliver AW, Batman G, He X, et al. A single-arm, proof-of-concept trial of lopimune (lopinavir\/ritonavir) as a treatment for HPV-related pre-invasive cervical disease. PLoS ONE. 2016;11:e0147917.","journal-title":"PLoS ONE"},{"issue":"70","key":"7251_CR40","first-page":"e63","volume":"2015","author":"CD Lahiri","year":"1999","unstructured":"Lahiri CD, Dugan KB, Xie X, Reimers L, Burk RD, Anastos K, et al. Oral Lopinavir Use and Human Papillomavirus Infection in HIV-Positive Women. J Acquir Immune Defic Syndr. 1999;2015(70):e63-66.","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07251-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07251-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07251-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T01:39:55Z","timestamp":1674956395000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07251-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,14]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7251"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07251-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,14]]},"assertion":[{"value":"27 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The procedures followed for human subjects were in accordance with the ethical standards of the Helsinki Declaration of the World Medical Association. The study was approved by the Institutional Review Board of Fudan University with IRB#2018-TYSQ-03-12, and all the participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"250"}}